New cancer clinical trial: SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer

Published on: November 27, 2018 at 12:00PM
Condition:   Small Cell Lung Cancer Extensive Stage
Intervention:   Drug: Epirubicin plus SHR1210
Sponsors:   Henan Cancer Hospital;   Jiangsu HengRui Medicine Co., Ltd.
Not yet recruiting
https://ift.tt/2Aq2gJ8